Coca-Cola (KO) Stock: 7 Surprising Facts You Need to Know (Oct 11, 2025)

Coca-Cola (KO) Stock: 7 Surprising Facts You Need to Know (Oct 11, 2025)

  • Price & Valuation: As of Oct 10, 2025, KO closed around $67.0 (market cap ~$288.6B) [1] [2]. It trades at a trailing P/E ~23.8x (forward ~22.5x) [3] [4], roughly in line with peers.
  • Recent Performance: The stock has been relatively flat recently – roughly +0.6% over the past week and –1.2%over the last month [5]. It’s up about +8.4% year-to-date (and +55.9% over 5 years), though it has slightly lagged the S&P 500 in 2025 [6].
  • Dividend: Coca-Cola is a Dividend King (raising payouts for over 60 years). It recently approved a quarterly dividend of $0.51 (≈$2.04/year), yielding about 3.0% [7]. The payout ratio (~72%) and long history of increases underscore KO’s focus on steady income.
  • Analysts & Targets: Wall Street consensus remains a “Buy”. The average 12-month price target is around $76.9, implying roughly +15% upside [8] [9]. Most brokers (UBS, RBC, JP Morgan, etc.) have “Outperform/Buy” ratings and targets in the mid-$70s to $80s [10] [11].
  • Recent News: In early Oct 2025, Coca-Cola announced it will roll out 7.5‑oz mini cans (priced ~$1.29) and introduce a cane-sugar sweetened Coke in the U.S., aiming to attract budget‑ and calorie-conscious shoppers [12] [13]. These moves respond to “choppy” soda demand (sales gains have come from price hikes, not volume [14]). Notably, in June 2025 Turkey’s antitrust authority launched a probe into Coke’s sales practices [15], a regulatory risk to watch.
  • Company Snapshot: Coca-Cola is the world’s largest soft-drink company, operating in 200+ countries with over 30 brands each generating more than $1 billion in sales [16]. Its portfolio ranges from flagship sodas (Coke, Diet Coke, Sprite, Fanta) to waters and juices. For example, KO holds a 19% stake in Monster Beverage (leading energy drinks) [17] and has expanded into new categories (like protein drinks and sparkling waters). The image below shows a Coke delivery truck in Los Angeles – a glimpse of its vast distribution network worldwide:

Figure: A Coca-Cola distribution truck in downtown Los Angeles (2018). The company’s products are delivered globally.

Coke sells roughly 2 billion servings per day (over 700 million ounces) worldwide. It is a Dow-30 component and one of the largest non-alcoholic beverage companies. In emerging markets, KO often drives growth (e.g. Coca-Cola and local brands like Thums Up achieved double-digit volume growth in India [18]).

Figure: Coca-Cola products (Coke, Sprite, etc.) on the shelf of a Sarajevo supermarket (Bosnia, 2024). The brand’s retail presence spans countless stores globally.

  • Earnings & Fundamentals: In Q1 2025 (ended Mar), Coke delivered organic revenue +6% and EPS +5% ($0.77), despite a 2% FX drag on net sales [19] [20]. For Q4 2024, revenue was $11.40 B (+4.2% vs. consensus –2.5%) and EPS $0.55 [21]. Management reaffirmed long-term targets (5–6% organic growth) and said its “all-weather strategy” helped navigate the weak demand environment [22] [23]. However, growth is largely coming from pricing; U.S. volumes are sluggish (Reuters notes Coke’s U.S. sales gains have been driven by higher prices, not more cases sold [24]). Currency headwinds remain a factor: strong USD trimmed $0.2B from Q1 revenue. (Coke expects inflation to moderate eventually, but warned consumers are feeling pressure [25].)
  • Technical Outlook: From a chart perspective, KO is in a tight trading range.  ChartMill notes KO has been stuck between about $65–$67 for weeks [26]. The stock closed just below key moving averages (50-day ≈$68.1 and 200-day ≈$69.9 [27]). ChartMill gives KO a very low technical rating (1/10), calling it a “bad performer” with negative medium- and short-term trends [28]. Immediate resistance lies around $68.0–$68.5, with support near $66.4 [29]. The RSI is around 30–35 (neutral to slightly oversold [30]). In summary, technical signals are mixed/bearish: KO needs to clear $68 to regain momentum, otherwise a break below $66–$65 could trigger further dips.
  • Analyst Commentary: Experts emphasize Coke’s stability. Truist analyst Bill Chappell says “Coca-Cola looks like one of the safest plays in what has become a minefield of challenges” (citing issues like tariffs, FX, and consumer health trends) [31]. Brian Mulberry of Zacks adds that Coke’s “diverse offerings have proven buoyant in the face of consumers cutting back on sugary drinks,” underpinning long-term demand [32]. MarketBeat notes that even after a 6% post-earnings dip (due to a big cash outlay), KO’s fundamentals are intact: it still trades at a premium P/E vs. PepsiCo (22.5× vs 17.1×) because of its unmatched global footprint [33]. Wall Street’s consensus target (~$77) assumes steady growth ahead [34]. Importantly, analysts highlight KO’s dependable dividend (yield ~3.1% [35]) as a cushion for income-focused investors.
  • Business Developments: Coca-Cola continues innovating. Under CEO James Quincey it has added new brands (e.g. Topo Chico water, Fairlife dairy, and a recent venture capital stake in the Celsius energy drink brand). Last year it launched Simply Pop (a prebiotic soda) and expanded ready-to-drink teas [36], targeting health-conscious consumers. On the flip side, it faces regulatory scrutiny: besides the Turkey probe [37], the company is watching shifts like soda taxes and labeling lawsuits. Coca-Cola also announced aggressive capital returns – for example, a new $6 billion share buyback program through 2030 (not yet completed) – highlighting its commitment to shareholders.
  • Macroeconomic Impact: Broader trends could sway KO stock. High inflation and interest rates have stressed U.S. consumers [38], potentially limiting soda purchases. Moreover, some analysts warn of an “Ozempic effect” – weight-loss drugs curbing junk-food and soda demand (PepsiCo’s CFO noted he’s monitoring this trend [39]). Trade/tariff news has also spooked markets: for instance, on Oct 10 global stocks tumbled (U.S. indices down ~2–3%) amid fears of a U.S.–China tariff escalation [40]. In such volatile times, KO’s low beta (0.43) and steady dividends make it a defensive favorite. Conversely, any easing of rates or inflation could boost consumer spending – Motley Fool notes that KO, a Dividend King, “could do even better if economic growth takes off” [41]. All told, macro factors (policy, inflation, consumer habits) are a double-edged sword: they pose risks to Coke’s pricing power and volume, but also reinforce its status as a reliable, income-oriented stock.

Sources: Authoritative analyses and news (Reuters, MarketBeat, SimplyWallSt, TS2.Tech, Motley Fool, etc.) have been used throughout this report to provide quotes and data [42] [43] [44] [45] [46] [47] [48]. Each cited figure is drawn from these linked sources for accuracy.

How Much $ Do You Need For $100 / Month in Dividends with Coca Cola Stock

References

1. stockanalysis.com, 2. www.marketbeat.com, 3. www.marketbeat.com, 4. www.marketbeat.com, 5. simplywall.st, 6. simplywall.st, 7. www.marketbeat.com, 8. www.marketbeat.com, 9. www.marketbeat.com, 10. www.marketbeat.com, 11. www.marketbeat.com, 12. www.reuters.com, 13. www.reuters.com, 14. www.reuters.com, 15. www.reuters.com, 16. investors.coca-colacompany.com, 17. www.reuters.com, 18. investors.coca-colacompany.com, 19. investors.coca-colacompany.com, 20. investors.coca-colacompany.com, 21. www.reuters.com, 22. investors.coca-colacompany.com, 23. www.reuters.com, 24. www.reuters.com, 25. www.reuters.com, 26. www.chartmill.com, 27. www.marketbeat.com, 28. www.chartmill.com, 29. www.chartmill.com, 30. www.chartmill.com, 31. www.reuters.com, 32. www.reuters.com, 33. www.marketbeat.com, 34. www.marketbeat.com, 35. www.marketbeat.com, 36. investors.coca-colacompany.com, 37. www.reuters.com, 38. www.reuters.com, 39. ts2.tech, 40. ts2.tech, 41. www.nasdaq.com, 42. www.reuters.com, 43. www.reuters.com, 44. simplywall.st, 45. www.reuters.com, 46. www.marketbeat.com, 47. ts2.tech, 48. www.reuters.com

Stock Market Today

  • Tilray Brands Soars 94.5% in 3 Months: Buy, Sell, or Hold?
    November 7, 2025, 12:30 PM EST. Tilray Brands (TLRY) has jumped 94.5% over the last quarter, outpacing an industry that slipped about 2.5%. The rally followed a CNBC report on potential federal rules for hemp products and hints that a Trump administration could ease marijuana restrictions, plus Tilray's Q1 results showing record net revenues of $210 million and a strengthened balance sheet. The company is expanding its Tilray Medical footprint globally, including the Solana Life Group venture in Panama, new EU products from Germany, and a strategic Italy partnership with Molteni. In Australia, it launched its first medical cannabis edible. On the bottom line, Q1 net income rose to $1.5 million from a year-ago loss, with adjusted net income of $3.9 million as costs were disciplined. Zacks pegs 2026 sales up about 6.8%, with earnings guidance still evolving.
  • Consolidated Edison Q3 2025 Earnings Beat: Adjusted EPS $1.90, Revenues Rise 10.7% YoY
    November 7, 2025, 12:28 PM EST. Consolidated Edison (ED) reported Q3 2025 adjusted EPS of $1.90, beating the Zacks Consensus by 7.9% and up 13.1% YoY, with GAAP EPS of $1.91. Total revenues reached $4.53 billion, topping estimates by 8.8% and rising 10.7% from the prior year. Segment highlights show electric revenues at $4.04 billion (+10%), gas at $433 million (+16.1%), and steam at $56 million (+14.3%); non-utility revenue was flat. Operating expenses climbed 10.2%, led by higher purchase power and fuel costs, while depreciation and taxes also rose. Operating income was $968 million (+12.3%). OCF for the first nine months: $3.11 billion. 2025 guidance narrowed to $5.60-$5.70 per share; Zacks Rank: #3 Hold.
  • Array Digital Infrastructure (AD) Q3 Earnings Beat Estimates; Revenue Tops Forecasts
    November 7, 2025, 12:26 PM EST. Array Digital Infrastructure (AD) posted Q3 earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.25 and marking a 288% surprise. The year-ago figure was $0.26 per share. The quarterly results came with adjusted items. The company also delivered revenues of $47.12 million, topping the consensus by 2.10%. Year over year, revenue comparison was weak due to prior period anomalies (year-ago revenues listed as $922 million). Over the last four quarters, AD has surpassed EPS estimates three times and revenue estimates three times. The stock has fallen ~24% YTD, underperforming the S&P 500 (+14.3%). Ahead, estimates call for $0.24 EPS on $55.11 million revenues next quarter and $1.05 EPS on $1.91 billion in the current fiscal year. Zacks Rank: #3 Hold.
  • Holley Inc. (HLLY) Q3 Earnings Miss; EPS Falls Short While Revenue Beats
    November 7, 2025, 12:24 PM EST. Holley Inc. (HLLY) reported Q3 earnings of $0.03 per share, missing the Zacks Consensus of $0.04. Year-ago EPS was a loss of $0.01. Excluding non-recurring items, the quarter delivered a -25% earnings surprise. Revenue rose to $138.37 million, beating the consensus by 5.02% and up from $134.04 million a year ago. Over the last four quarters, the company has topped consensus only once on EPS. The stock has fallen about 9.6% year-to-date, underperforming the S&P 500 (+14.3%). Ahead of the call, investors will watch management tone and revisions; current guidance is for next quarter EPS of $0.08 on $139.34 million in revenue and $0.23 on $590.8 million for the full year. Zacks Rank remains #3 (Hold).
  • DoubleVerify Holdings (DV) Beats Q3 EPS, Faces Cautious Outlook
    November 7, 2025, 12:22 PM EST. DoubleVerify Holdings (DV) posted Q3 2025 results with an adjusted EPS of $0.22, topping the Zacks Consensus estimate of $0.09 and delivering a striking earnings surprise of +144.44%. Revenue came in at $188.62 million, missing the consensus by 0.82%. The company also noted a prior-quarter miss: estimates of $0.06 vs $0.05 actual, a -16.67% surprise. Over the last four quarters, DV has topped consensus EPS only once. The stock has fallen about 42.9% YTD, versus the S&P 500's 14.3% gain. Management commentary on the earnings call will shape the price path, as near-term movement hinges on outlook and revisions. Ahead of the release, estimate revisions were unfavorable, contributing to a Zacks Rank #4 (Sell). Next-quarter EPS estimate: $0.16 on $210.93M revenue; current fiscal year: $0.31 on $755.17M.
Circle (CRCL) Stock’s Wild Ride: Stablecoin Boom, Volatile Swings & 2025 Outlook
Previous Story

Circle (CRCL) Stock’s Wild Ride: Stablecoin Boom, Volatile Swings & 2025 Outlook

Merck (MRK) Stock Could Skyrocket: Key Drug Approvals & Analyst Targets Unveiled
Next Story

Merck (MRK) Stock Could Skyrocket: Key Drug Approvals & Analyst Targets Unveiled

Go toTop